Description
GSK-1904529A is an inhibitor of the insulin receptor (InsR) and IGF-1R that exhibits anticancer chemotherapeutic activity. In cellular and animal models of multiple myeloma and Ewing’s sarcoma, GSK-1904529A induces cell cycle arrest and inhibits cell proliferation and tumor growth.